News & Events

Strategic Positioning Plan for Eisai/Biogen’s Alzheimer’s Drug Lecanemab Following Aducanumab’s Controversy.

PMPRB Guideline Amendments: Potential Solutions During a Time of Change for Novo Nordisk.

Bridging the Efficacy Gap Between Clinical Data and Real World Evidence for Roche-Genentech Through Digital Solutions.

Leveraging the Microbiome to Improve Entyvio’s Market Share.

Biogen Whistleblower Settlement: Solutions to Maintain Leading Reputation.

The New Blue: Restoring Bluebird Bio.

Mitigation of the Tocilizumab (Actemra®) Shortage During COVID-19 in Canada.

Biopartnering Seminar Series · Accelerating Clinical Trials: Innovative Clinical Trial Designs with an Introduction to Bayesian Thinking.

Drug Discovery, Licensing and Translation of OICR-9249.

The Use of Analytics & Insights in Pharma.

The Value of Patient Support Programs.